This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dewanjee, M. K. Articles by Kaye, M. P. Search for Related Content PubMed PubMed Citation Articles by Dewanjee, M. K. Articles by Kaye, M. P.

Circulation, Vol 69, 350-356, Copyright © 1984 by American Heart Association

ARTICLES

Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin

MK Dewanjee, M Tago, M Josa, V Fuster and MP Kaye

Autologous femoral vein segments were implanted as aortocoronary bypass grafts in 50 dogs, 25 of which were treated with dipyridamole and aspirin to inhibit platelet deposition and 25 that were not. Autologous platelets labeled with indium-111 were injected into some dogs 48 hr before they were killed on the first day after surgery; other dogs were injected 24 hr before they were killed (3, 7, 30, and 90 days after surgery). Radioactivity on the grafts and on control specimens of contralateral femoral veins was converted to quantification of platelets adhering to the vessel wall (platelets/cm2). The treated group had fewer graft platelets per square centimeter than the untreated group on postoperative days 3, 7 (p less than .01), and 30 (p less than .05). Graft and control vein platelets per square centimeter were nearly equal by day 90. Comparison of graft and control specimens by scanning electron microscopy nearly equal by day 90. Comparison of graft and control specimens by scanning electron microscopy revealed deendothelialization at 1 and 7 days after grafting and reendothelialization at 30 and 90 days. The data suggest that indefinite prolongation of therapy to inhibit platelet deposition after bypass grafting may be unnecessary (although other atherosclerotic vessels may benefit from therapy).

This article has been cited by other articles:

				M. R Miller, I. S Hanspal, P. W.F Hadoke, D. E Newby, A. G Rossi, D. J Webb, and I. L Megson A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury Cardiovasc Res, March 1, 2003; 57(3): 853 - 860. [Abstract] [Full Text] [PDF]

				J. S. Mruk, M. W. I. Webster, M. Heras, J. M. Reid, D. E. Grill, and J. H. Chesebro Flavone-8-Acetic Acid (Flavonoid) Profoundly Reduces Platelet-Dependent Thrombosis and Vasoconstriction After Deep Arterial Injury In Vivo Circulation, January 25, 2000; 101(3): 324 - 328. [Abstract] [Full Text] [PDF]

				J. St. Pierre, L.-Y. Yang, K. Tamirisa, D. Scherrer, P. De Ciechi, P. Eisenberg, E. Tolunay, and D. Abendschein Tissue Factor Pathway Inhibitor Attenuates Procoagulant Activity and Upregulation of Tissue Factor at the Site of Balloon-Induced Arterial Injury in Pigs Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2263 - 2268. [Abstract] [Full Text] [PDF]

				R. H. Heijmen, P. F. Grundeman, and C. Borst Intima-Adventitia Apposition in End-to-Side Arterial Anastomosis: An Experimental Study in the Pig Ann. Thorac. Surg., March 1, 1998; 65(3): 705 - 711. [Abstract] [Full Text] [PDF]

				M. K. Dewanjee Stroke From Heparin-Coated Circuits and Reduced Systemic Anticoagulation Ann. Thorac. Surg., October 1, 1997; 64(4): 1218 - 1219. [Full Text]